Bendamustine Archives - Medical Conferences

ECHO: Can we expect a novel standard of care in newly diagnosed MCL?

Presented By

Prof. Michael Wang, University of Texas, TX, USA

Trial

Phase 3, ECHO

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:26

Novel first-line treatment option for mantle cell lymphoma

Presented By

Prof. Michael Wang, Anderson Cancer Center, TX, USA

Trial

Phase 3, SHINE

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 14:30

Novel anti-CD19 plus lenalidomide prolonged survival in R/R DLBCL

Expert

Dr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA

Trial

Cohort study, RE-MIND2

Conference

ASH 2021

Type

News article

4 February 2022 11:08

Ibrutinib continues to outperform chemoimmunotherapy in patients with treatment-naïve CLL

Expert

Dr Jennifer Woyach, Ohio State University, OH, USA

Trial

Phase 3, Alliance A041202

Conference

ASH 2021

3 February 2022 23:22

Two trials: acalabrutinib in CLL

Presented By

Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA

Trial

Phase 2, ACE-CL-001, ASCEND

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 12:19

ASCEND study: Acalabrutinib improves progression-free survival in relapsed/refractory CLL

Presented By

Dr Paolo Ghia, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, ASCEND

Conference

EHA 2019

Type

Peer-reviewed article

9 August 2019 15:28